Training Videos

We developed these videos to help you maximize patient outcomes in your practice.

What is Migraine

Migraine is a genetic, neurological disease that affects almost 48 million people in the United States – that’s nearly 1 in 5 patients in your practice. Learn about how disruptive migraine can be on the lives of these patients.

Light Sensitivity and Migraine

90% of people with migraine experience light sensitivity during an attack. Learn about the key role light plays in migraine, including triggering migraine attacks and worsening migraine-related headache pain.

What is Avulux

Avulux is the only lens that has been clinically proven for people living with migraine and light sensitivity. Learn how Avulux lenses work, and how this technology ultimately impacts the lives of patients.

Maximizing Avulux in Your Practice

Avulux can be easily integrated into your current patient flow using a few simple tools. Learn how to ensure that you are quickly and reliably identifying patients living with migraine in your own practice.

White Glove Onboarding

Dedicated Avulux representatives are available to enable you and your team

Trusted by Over 1,400 ECPs

There are over 1,400 Avulux Authorized Providers globally

Ongoing Support & Resources

Avulux providers have access to our team and a suite of tools to help you better serve your patients

Over 50,000

Over 50,000 Avulux wearers are managing the impact of light on their lives.

Become an
Avulux Provider

Become an Avulux Provider

Indications for Use: Avulux® is an FDA-authorized, over-the-counter precision optical filter indicated to block light at 480 nm (high blue range) and 590 nm (red/amber range), while allowing light in the remaining visible color spectrum through, to decrease the impact of light sensitivity in patients diagnosed with episodic migraine aged 12 years and older. The use of Avulux should not alter the usual care therapy of patients diagnosed with episodic migraine, including medication usage.

Avulux is intended to be used as an adjunct to usual care for migraine, including medication. It is not intended to diagnose, treat, cure, or prevent migraine or any other disease and is not a substitute for professional medical advice, diagnosis, or treatment. Consult a qualified healthcare professional regarding migraine symptoms and treatment. Avulux is classified by the U.S. Food and Drug Administration as a Class I medical device under 21 CFR § 882.5811, product code QEO. De Novo request DEN250026.